Jo Viney
About Jo Viney
Jo Viney: Founder, President, and CEO
Jo Viney is the Founder, President, and Chief Executive Officer of a distinguished organization. With a career spanning 30 years, she has successfully brought 13 drugs to clinical trials. Her leadership and strategic vision have shaped the company’s direction and growth.
Jo Viney's Education and Expertise
Jo Viney holds a PhD in immunology from the University of London, alongside a BSc (Hons) in biophysics from the University of East London. Her academic credentials have laid a strong foundation for a successful career in biotechnology and drug discovery.
Jo Viney's Professional Background
Jo Viney’s career includes impactful roles at Immunex, Amgen, and Biogen, where she was the senior vice president of the drug discovery organization. She founded Pandion Therapeutics in 2017 and served as President and Chief Scientific Officer until its acquisition by Merck for $1.85 billion in 2021.
Jo Viney's Board Memberships and Recognitions
Jo Viney serves as an independent board director for Graphite Bio, Zag Bio, and Lab Central. She has received several accolades, including being named one of the 2023 Extraordinary Women Advancing Healthcare in Massachusetts by The Women's Edge and featuring in Endpoints' 2019 Special Report on 20 Extraordinary Women and FiercePharma's 2020 Fiercest Women in Life Sciences.
Jo Viney's Advocacy and Volunteer Work
Jo Viney is a strong advocate for workplace inclusiveness and regularly volunteers with organizations focused on increasing diversity in STEM careers. She served on the board of WEST, a non-profit organization supporting early to mid-career women, including as President from 2017-2018.